| Value | ₹2.00 Cr |
|---|
NSE filing, NSE: INDUSTOWER. Summary written from the filing by ALFA Finder's alert engine.
Indus Towers Ltd: key numbers
- Share price
- ₹387.00
- Market cap
- ₹1,02,097 Cr
- Revenue (annual)
- ₹32,493 Cr
- Net profit (annual)
- ₹7,145 Cr
- P/E (TTM)
- 14.4×Sector 38.5×
- Promoter holding
- 51.26%+0.00% QoQ
- FII holding
- 21.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indus Towers Ltd
All →Indus Towers Other Announcement
Indus Towers informed exchanges that its RTA, KFin Technologies, is shifting its corporate office effective 1 December 2026. The RTA's registered office remains unchanged.
Indus Towers Earnings Call Transcript: Key Takeaways
Indus Towers delivered steady operational growth driven by strong co-location additions and network expansion from a major customer.
Indus Towers Results Update
Indus Towers released its Q2 and half-year quarterly report with audited results. Headline revenue and profit figures are not visible in these pages.
Indus Towers Q2 FY27 Results: Net Profit ₹1,793 Cr, Down 2.5% YoY
Indus Towers Ltd reported revenue from operations of ₹8,516 Cr (+4.0% YoY) and net profit of ₹1,793 Cr (-2.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,793 Cr · -2.5% YoY
Indus Towers Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
Indus Towers Board Meeting Date
Indus Towers announced a board meeting on October 27, 2026, to consider and approve its audited financial results for the second quarter ended September 30, 2026.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr